Skip to main content
    Back to episode
    Episode 68 · April 23, 2026 · 43m listen · 7,854 words · ~39 min read

    De-Risking Product Decisions in MedTech Startups with Brent Lavin of Ironwood MedTech | Ep. 67 - Full Transcript | The Med Device Cyber Podcast

    Read the complete, searchable transcript of Episode 68 of The Med Device Cyber Podcast - expert conversations on medical device cybersecurity, FDA premarket and postmarket guidance, SBOM management, threat modeling, and penetration testing.

    Prefer the listening experience? Open the episode page for the synopsis, key takeaways, topics, and Apple / YouTube listen links.

    Episode summary

    In this interview, Brent Lavin of Ironwood MedTech Partners, discusses de-risking product decisions for MedTech startups, especially when it comes to medical device cybersecurity and regulatory compliance. He emphasizes the importance of deeply understanding customer needs and the clinical workflow early in the product design process to avoid costly reworks, a common pitfall for many innovators. Lavin highlights the need for strategic trade-offs in product features, differentiating between essential and “nice-to-have” functionalities to streamline development and regulatory pathways.The discussion also explores the complexities of market adoption and reimbursement strategies, stressing the influence of economic buyers in hospitals. Lavin advocates for a “bottom-up” approach to revenue projection, focusing on tangible sales tactics rather than high-level market sizing. He shares insights on the advantages of being a “second-mover” in the market, learning from predecessors' clinical trial experiences and regulatory navigation. The episode touches upon the strategic utilization of 510(k) and PMA pathways, weighing quicker market entry against the ability to make differentiated clinical claims. Lavin underscores that success in MedTech requires an integrated approach, balancing engineering, marketing, and regulatory perspectives to launch impactful, sticky, and sustainable medical devices.

    Key takeaways from this episode

    • Prioritize customer interactions and clinical workflow understanding at the forefront of product design to avoid costly reworks and ensure market acceptance.
    • Make smart, cogent product decisions by differentiating between essential and 'nice-to-have' features, satisfying the majority's needs without over-complicating the device.
    • Develop a 'bottom-up' revenue ramp strategy focusing on specific sales tactics and real-world adoption, rather than solely relying on top-down total addressable market (TAM) figures.
    • Consider the advantages of being a 'second mover' in the MedTech market, as it allows learning from the initial innovator's clinical trial and regulatory experiences.
    • Carefully weigh the trade-offs between a faster 510(k) regulatory pathway, which may limit clinical claims, and a longer PMA pathway, which allows for differentiated claims and potentially higher margins.
    • Embrace an iterative product development process, treating marketing and product management as sciences that involve hypothesizing, testing, gathering feedback, and making continuous adjustments.
    • Focus on product stickiness and customer retention as key metrics for long-term business model scalability and attractiveness to strategic partners.
    • Strategically choose between capital, disposable, or mixed business models for devices, performing scenario analysis to align with overall company goals and market dynamics.

    Full episode transcript

    Page 1 of 10· Paragraphs 1 - 9
    You spend $35 million in seven years developing a product that doesn't have a home, basically. Customer interactions need to be really at the forefront of your product design and there needed to be trade-offs in that program to say we're not going to do this and we're going to do that. A great medical device should be easy to integrate and almost impossible to remove. If we could design a product that was simplified and sufficient for their needs at a much smaller footprint, which we did, and bring it into their environment, then it stays, then it's sticky. But it's often the second mover that learns from the first and then eventually takes share. So if you want to live life on hard mode, you know, join me. Hello and welcome back to the Med Device Cyber Podcast. I'm your co-host Trevor Slatterie, joined with Christian Espinosa. And today we're going to be talking about cybersecurity. We might even pivot a little bit into Formula 1. We'll see how things go. We're joined here today by Brent. I'd love to hear a little bit about yourself and where you're coming in from and what you're working on. Yeah, my name is Brent Lavin. I live here in Phoenix, Arizona, in the great desert. I moved out here about 15 years ago to follow my MedTech career journey, which started in Wisconsin. I had an engineering degree from undergrad and I did some product development work with a CDMO and then realized I liked the engineering side, but I really liked the customer side. So I went back and got my MBA so that I could work in this role of product management and really at the intersection of innovation strategy and marketing. So I was fortunate enough to start my career at GE Healthcare in the imaging space and doing some procedural devices there and ultrasound. And then about 15 years ago, like I mentioned, got the recruiter called to come out here to Phoenix, which was CRB at the time, and I started in the breast biopsy business. And just through growth and opportunity, moved over into peripheral vascular, which is really heavy procedural devices in the cath lab and IR suite. And so I spent the last 10 years in the Class 3 PMA world of product development and then did a couple of buy-side transactions on the commercial side. And then about six months ago, I launched Ironwood MedTech Partners, which is my offering to help early-stage Series A and B companies to de-risk their product decisions, align their story, and ultimately achieve commercialization or exit plans that will help make them successful. Awesome. You're just down the road from me. I'm in Tempe today. I live here, but I'm rarely here. I just got back from Korea a couple days ago. So I feel like I'm here 30 days a year these days, at most. Yeah, at most. As long as you pick the right 30 days. But we love it here and yeah, never looked back after we made the move. So, are you proper Phoenix or one of the outlying areas? Yeah, everybody says Phoenix. You don't realize how big it is until you get here. I'm in South Chandler. Okay. Yeah, I was born in Flagstaff, lived there until not too long ago and now moved over to San Francisco. Awesome. Most people do the opposite move from California to Phoenix, but Trevor decided to do the reverse. I wanted to live life on hard mode. I went from living in Flagstaff and, you know, everything being nice and open to going, Okay, let's fight for survival in a tiny one-bedroom apartment in the city. For three times the price per square footage. Maybe five times per square footage, actually. Probably about that. Is it really about five times per square foot? I would say probably about four times per square foot. Okay, interesting. But, you know, San Francisco is a beautiful area as well. You got the ocean there and it's a cool place to go. Quick short drive across that place to hike right across the Golden Gate Bridge is a pretty nice area there as well. You know, it's kind of funny. Coming out here was a bit of a move towards, you know, being more in the MedTech space. But in Arizona, obviously, there are a ton of MedTech companies. And where I lived in Flagstaff was literally right across the street from, oh gosh, now I'm blanking on the name. The big W. Gore. Yep. Gore. Right across the street. You could walk from my house over there. Yeah. Well, I live right across the street from BD just down right across Tempe Town Lake from where I am.
    1 / 10